The alternatives
NexLife scores 69/100 (grade C, ranked #192) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
NexLife — FDA warning letter, June 2026. Addressed to Nexlife Inc. dba Nexlife, and public in FDA’s warning-letter database.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to NexLife's 69, and our NexLife vs CoreAge Rx ruling sets the two out factor by factor.
MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.
MedLeanRx matches NexLife at 69/100; our full write-up on MedLeanRx has the pricing conditions and the caveats in detail.
Nova MD is a telehealth platform offering compounded semaglutide and tirzepatide on 1-month and 3-month plans, with an uncommon explicit microdose program for both molecules.
Nova MD matches NexLife at 69/100; the full Nova MD review has the pricing conditions and the caveats in detail.
MediRX is a telehealth weight-loss platform offering compounded GLP-1 injections — semaglutide starting at $149/month and tirzepatide starting at $199/month — plus NAD+ and a name-brand GLP-1 option.
MediRX matches NexLife at 69/100; the full MediRX review has the pricing conditions and the caveats in detail.
NP2GO is a nurse-practitioner-led hybrid telehealth and clinic operation based in Edmond, Oklahoma, founded in 2019 and affiliated with the Obesity Medicine Association.
NP2GO matches NexLife at 69/100; the full NP2GO review has the pricing conditions and the caveats in detail.
Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with…
Maves matches NexLife at 69/100; the full Maves review has the pricing conditions and the caveats in detail.
NuvaHealth (nuvahealth.org) is a LegitScript-certified compounded GLP-1 telehealth platform offering compounded semaglutide starting at $159 first-month and compounded tirzepatide starting at $259 first-month.
NuvaHealth matches NexLife at 69/100; the full NuvaHealth review has the pricing conditions and the caveats in detail.
See the complete rankings or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.